Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 7Unspecified Adult Solid Tumor, Protocol Specific 2Male Urogenital Diseases 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Nodule 1Rectal Neoplasms 1Prevention of Colorectal Cancer 1Precancerous Conditions 1Polyps 1Ovarian Neoplasms 1Non-melanoma Skin Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Inflammation 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Breast Cancer Risk 1Arsenic Poisoning 1Adenomatous Polyps 1

Interventions

Oxaliplatin 269Bevacizumab 259Fluorouracil 248Irinotecan 240Leucovorin 217Capecitabine 196Cetuximab 160Colonoscopy 74Folfox protocol 70Panitumumab 64regorafenib 62Drug Therapy 52Radiotherapy 50HMPL-013 50Blood Specimen Collection 45trifluridine tipiracil drug combination 43pembrolizumab 41Surveys and Questionnaires 35Standard of Care 34Nivolumab 34Neoadjuvant Therapy 34Surgical Procedures, Operative 33Magnetic Resonance Spectroscopy 30IFL protocol 27Trifluridine 26Interviews as Topic 26Celecoxib 26XELOX 25Early Intervention, Educational 24Methods 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Colorectal Neoplasms × Selenium × Clear all
NCT00078897 2019-09-24

Selenium for Prevention of Adenomatous Colorectal Polyps

University of Arizona

Phase 3 Terminated
1,621 enrolled 12 charts
GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡